MRK

Merck & Co., Inc. · BIVA:MRK

2,814.00 MXN10.50 +0.37%

Merck & Co., Inc. (BIVA:MRK) last traded at 2,814.00 MXN, up 0.37% on the day. Over the past year the stock is up 76.57%. Its 52-week range is 1,524.70 to 2,914.99. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open2,753.17

Day range2,753.17 – 2,914.99

52-week range1,524.70 – 2,914.99

Volume111

Average volume (10 days)54

Market cap (USD)368.89 B

P/E158.89

EPS (TTM) (USD)0.9792

Dividend yield2.27%

Beta (1 year)−0.3242

Revenue (TTM) (USD)67.19 B

Employees75.00 K

Performance

+2.20%1 week

+4.31%1 month

+22.47%3 months

+44.97%6 months

+48.51%Year to date

+76.57%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Merck Stocks Decline With Higher Target Leaving a New-Launch Scale TestGuruFocus · 02 Nov 2026
Merck Is Maintained at Neutral by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
Merck to Present New Data from Its Broad Oral HIV Portfolio and Pipeline at HIV Glasgow 2026BusinessWire · 02 Nov 2026
From Near Miss To Crown Jewel: The Rise, Reign And Road Ahead For Merck's Keytrudadpa-AFX · 01 Nov 2026
Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
Merck Price Target Raised to $175.00/Share From $165.00 by JP MorganDow Jones Newswires · 30 Oct 2026
Merck Stocks Rise 2.6% With Qlex Still Under 10% of Keytruda SalesGuruFocus · 30 Oct 2026
Merck One of Top Large-Cap Biopharma Picks-AnalystBenzinga · 30 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.